Table 2.
Clinical trials studies evaluating effect of vitamin D supplementation versus placebo in CAD patients.
F female, M male, CAD coronary artery disease, I intervention group, P placebo group, IL interleukin, ICAM intercellular adhesion molecule; VCAM vascular cell adhesion protein, hs-CRP high-sensitivity C-reactive protein, TNF tumor necrosis factor, TC total cholesterol, TG triglyceride, LDL low density lipoprotein, HDL high density lipoprotein, SBP systolic blood pressure, DBP diastolic blood pressure, PTH parathyroid hormone.
